Bausch & Lomb Incorporated
Clinical trials sponsored by Bausch & Lomb Incorporated, explained in plain language.
-
New laser tested to sharpen vision for farsighted adults
Disease control OngoingThis study is testing the safety and effectiveness of a specific laser model (TENEO 317) when used during LASIK surgery to correct farsightedness, with or without astigmatism. It involves about 140 adults who have stable vision prescriptions and rely on glasses or contacts. Resea…
Phase: NA • Sponsor: Bausch & Lomb Incorporated • Aim: Disease control
Last updated Mar 25, 2026 14:07 UTC
-
New lens aims to sharpen vision after cataract surgery
Disease control OngoingThis study is testing a new type of artificial lens (the enVista Beyond) for people having cataract surgery. It aims to see if this lens provides better vision at arm's length and for reading compared to a standard lens. About 304 participants will have the new lens or the standa…
Phase: NA • Sponsor: Bausch & Lomb Incorporated • Aim: Disease control
Last updated Mar 16, 2026 15:24 UTC
-
Extended safety check for dry eye combo drug halted
Symptom relief TerminatedThis study was designed to check the long-term safety of a combination eye drop (lifitegrast/perfluorohexyloctane) for people with dry eye disease. It was meant to last 12 months and was only open to people who had successfully completed a specific earlier trial. However, the stu…
Phase: PHASE3 • Sponsor: Bausch & Lomb Incorporated • Aim: Symptom relief
Last updated Mar 02, 2026 15:23 UTC
-
First human test for new eye pain drops begins
Knowledge-focused OngoingThis is a very early study to check if a new type of eye drop called BL1332 is safe for people. It will be tested on 24 healthy volunteers to see what side effects might occur and how the drug is absorbed into the body. The main goal is to find the highest dose that people can to…
Phase: PHASE1 • Sponsor: Bausch & Lomb Incorporated • Aim: Knowledge-focused
Last updated Mar 30, 2026 14:35 UTC